Meeting report, 25-26 September 2017 Copenhagen, Denmark
Osoianu and Halacu BMC Infectious Diseases 2014, 14(Suppl 4):P8 http://www.biomedcentral.com/1471-2334/14/S4/P8
From The 7th Romanian National HIV/AIDS Congress and The 2nd Central European HIV... Forum Sibiu, Romania. 29-31 May 2014
more
In the framework of the United Nations Sustainable Development Goals Issue-based Coalition on Health and Well-being for All at All Ages in Europe and Central Asia
SDG target 3.3: by 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, waterborne diseases and other communicable diseases.
Toolkit
HIV Treatment and Care
Downloaded from https://aidsinfo.nih.gov/guidelines on 10/19/2019
Developed by the HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV—A Working Group of the Office
of AIDS Research Advisory Council (OARAC)
Frontiers in Public Health | www.frontiersin.org 1 June 2017 | Volume 5 | Article 127
Recommendations for a Public Health approach and considerations for policy-makers and managers
Journal of Social Aspects of HIV/AIDS VOL. 13 NO. 1 2016
To link to this article: https://doi.org/10.1080/17290376.2016.1226942
Practical Guideline for collaborative interventions
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured ...bute-to-highlight medbox">HIV genotyping laboratory services producing comparable and reliable results at the national, regional and global levels.
This publication updates the WHO HIVResNet HIV drug resistance laboratory operational framework published in 2017 and reflects technical and strategic developments over the past three years.
more
PQDx 0006-005-00 WHO
PQDx PR
February/2016, version 2.0
Accountability for the global health sector strategies, 2016–2021
WHO/CDS/HIV/19.7
HIV testing services
Policy Brief
November 2018
WHO/CDS/HIV/18.48